AU2003242250A1 - Cyclic amine and medicinal composition containing the same - Google Patents

Cyclic amine and medicinal composition containing the same

Info

Publication number
AU2003242250A1
AU2003242250A1 AU2003242250A AU2003242250A AU2003242250A1 AU 2003242250 A1 AU2003242250 A1 AU 2003242250A1 AU 2003242250 A AU2003242250 A AU 2003242250A AU 2003242250 A AU2003242250 A AU 2003242250A AU 2003242250 A1 AU2003242250 A1 AU 2003242250A1
Authority
AU
Australia
Prior art keywords
same
composition containing
medicinal composition
cyclic amine
medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003242250A
Inventor
Nobuyuki Sawada
Yoshihide Ueno
Takashi Umezome
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharmaceuticals Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Publication of AU2003242250A1 publication Critical patent/AU2003242250A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003242250A 2002-06-12 2003-06-10 Cyclic amine and medicinal composition containing the same Abandoned AU2003242250A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002171411 2002-06-12
JP2002-171411 2002-06-12
PCT/JP2003/007383 WO2003106423A1 (en) 2002-06-12 2003-06-10 Cyclic amine and medicinal composition containing the same

Publications (1)

Publication Number Publication Date
AU2003242250A1 true AU2003242250A1 (en) 2003-12-31

Family

ID=29727808

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003242250A Abandoned AU2003242250A1 (en) 2002-06-12 2003-06-10 Cyclic amine and medicinal composition containing the same

Country Status (3)

Country Link
JP (1) JPWO2003106423A1 (en)
AU (1) AU2003242250A1 (en)
WO (1) WO2003106423A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021353009A1 (en) * 2020-09-30 2023-06-08 Katholieke Universiteit Leuven 1,2,3,4-tetrahydroquinoline derivatives as inhibitors of the yap/taz-tead activation for treating cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08198866A (en) * 1995-01-20 1996-08-06 Tokyo Tanabe Co Ltd New 2-amino-1-phenylethanol compound
JPH08259558A (en) * 1995-03-20 1996-10-08 Tokyo Tanabe Co Ltd 2-amino-1-phenylethanol compound
FR2758460B1 (en) * 1997-01-21 1999-12-31 Sanofi Sa USE OF ADRENERGIC BETA-3 RECEPTOR AGONISTS FOR THE PREPARATION OF HEALING MEDICINAL PRODUCTS
AU2790999A (en) * 1998-03-03 1999-09-20 Merck & Co., Inc. Fused piperidine substituted arylsulfonamides as beta3-agonists
EP1070046A1 (en) * 1998-04-06 2001-01-24 Fujisawa Pharmaceutical Co., Ltd. Propanolamine derivatives

Also Published As

Publication number Publication date
WO2003106423A1 (en) 2003-12-24
JPWO2003106423A1 (en) 2005-10-13

Similar Documents

Publication Publication Date Title
IL162548A0 (en) 4-Oxoquinoline derivatives and pharmaceutical compositions containing the same
IL166482A0 (en) Dihydropyrazolopyridine derivatives and pharmaceutical compositions containing the same
IL164021A (en) Anti-alphavbeta6 antibodies and pharmaceutical compositions containing the same
AU2003289440A1 (en) Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof
IL166129A0 (en) Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL173602A0 (en) Heteroarylaminosulfonylphenyl derivatives and pharmaceutical compositions containing the same
IL173051A0 (en) N-glucoside derivatives and pharmaceutical compositions containing the same
IL171997A0 (en) Pyrrolodihydroisoquinoline derivatives and pharmaceutical compositions containing the same
IL164987A (en) Proline derivatives and pharmaceutical compositions containing the same
AU2003261974A1 (en) Amine compounds and use thereof
IL175214A0 (en) 2-cyanopyrrolidinecarboxamide derivatives and pharmaceutical compositions containing the same
IL173639A (en) Ppar-activating compound and pharmaceutical composition containing same
IL233352A0 (en) Rna molecules and pharmaceutical compositions containing the same and uses thereof
IL176005A0 (en) 2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same
IL172159A0 (en) 2-oxo-pyridine derivatives and pharmaceutical compositions containing the same
IL172338A0 (en) Cyclic tertiary amine compounds and pharmaceutical compositions containing the same
AU2003254950A1 (en) Peptides and drugs containing the same
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
IL164455A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
EP1405859A4 (en) Nitrogenous heterocyclic derivative, medicinal composition containing the same, medicinal use thereof and intermediate therefor
IL175499A (en) Detoxified pneumococcal neuraminidase and pharmaceutical compositions containing the same
IL165775A0 (en) Novel quinuclidine derivatives and medicinal compositions containing the same
HUP0401733A3 (en) Cyclic amine-derivatives and pharmaceutical compositions containing them
IL173626A0 (en) Small peptides and oral pharmaceutical compositions containing the same
HUP0401644A3 (en) Aminobenzoephenones, pharmaceutical compositions containing them and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase